“…When it comes to cancer imaging, nanodroplet-based ULM has the potential to offer enhanced insights into tumor angiogenesis, characterized by the presence of vessels with very slow flows . Nanodroplets are invisible to ultrasound before activation, and when nanodroplets are acoustically or optically activated, they form transient microbubbles that immediately exhibit hyperechogenicity in ultrasound imaging, and as droplets are activated and deactivated at the ultrasound pulse repetition frequency, the signal can accumulate as quickly as sending imaging pulses, enabling fast cumulative localization, resulting in faster super-resolution imaging. − Third, the nanodroplets can extravasate into the cancerous space due to the leaky vasculature of cancerous endothelial walls and the EPR effect, which make them useful in cancer extravasation imaging. ,, Many studies have tried to verify that nanodroplets can extravasate within a range of sizes, usually with an optimum exosmosis size of 100–300 nm. , Rapoport et al performed experiments on mouse thigh subcutaneous muscle and adipose tissue under a microscope, observed the vasculature, and found that the extravasation rate of nanodroplets into the normal tissue was very slow . Song et al have demonstrated that cavitation-facilitated permeability was enhanced across the blood–brain barrier in rats induced by acoustically vaporized nanodroplets .…”